home / stock / pyxs / pyxs articles

PYXS Articles, Pyxis Oncology Inc. - From 03/07/24

Stock Information
Company Name: Pyxis Oncology Inc.
Stock Symbol: PYXS
Market: NASDAQ
Website: pyxisoncology.com
Menu
PYXS PYXS Quote PYXS Short PYXS News PYXS Articles PYXS Message Board
Get PYXS Alerts

News, Short Squeeze, Breakout and More Instantly...
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024 | Benzinga

BOSTON, March 07, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical stage company focused on developing next generation th...
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting | Benzinga

PYX-201, an EDB+FN-specific tumor stroma-targeting ADC, demonstrates potent anti-tumor efficacy across multiple human cancers in PDX tumor models ...

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. Helix Energy posted ...

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Benzinga

BOSTON, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company focused on developing next-generation the...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of NAPCO Security Technologies Inc. (NASDAQ: PYXS) | Benzinga

NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that it has commenced an investigation of NAPCO Security Technologies...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ: PYXS) | Benzinga

NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that it has commenced an investigation of Pyxis Oncology, Inc. (NASD...

Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 | Benzinga

BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company focused on developing next-generation th...
Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst | Benzinga

RBC Capital Markets has initiated coverage on Pyxis Oncology Inc (NASDAQ: PYXS) with an Outperform rating and a price target of...

Pyxis Oncology to Participate in Two Upcoming Investment Conferences | Benzinga

BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company focused on developing next-generation the...

Previous 10 Next 10